Mitchell Mcleod Pugh & Williams Inc Biogen Inc. Transaction History

Mitchell Mcleod Pugh & Williams Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$282.99 - $369.05 $191,018 - $249,108	-675 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$259.0 - $414.71 $174,825 - $279,929	675 New	675 $234,000
Q2 2020 Jul 17, 2020	SELL	$258.66 - $342.55 $169,422 - $224,370	-655 Closed	0 $0
Q1 2020 Apr 08, 2020	BUY	$268.85 - $341.04 $176,096 - $223,381	655 New	655 $207,000
Q4 2018 Jan 10, 2019	SELL	$278.5 - $352.75 $164,315 - $208,122	-590 Closed	0 $0
Q3 2018 Oct 09, 2018	SELL	$293.51 - $383.83 $42,558 - $55,655	-145 Reduced 19.73%	590 $208,000
Q3 2017 Oct 12, 2017	BUY	$281.15 - $329.69 $206,645 - $242,322	735	735 $230,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.